Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy
Clinical trial NCT04437160 · RECRUITING
Trial details
- NCT number
- NCT04437160
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-01
- Primary completion
- 2026-01-01
- Enrollment
- 286
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.